Eppendorf
Eppendorf AG, a leading name in the life sciences industry, is headquartered in Hamburg, Germany (DE). Founded in 1945, the company has established itself as a pioneer in laboratory equipment and consumables, serving researchers and scientists across the globe. Eppendorf's core business areas include liquid handling, sample handling, and cell culture, with innovative products such as pipettes, centrifuges, and bioreactors that are renowned for their precision and reliability. With a strong presence in Europe, North America, and Asia, Eppendorf has achieved significant milestones, including numerous awards for product excellence and sustainability initiatives. The company is committed to advancing scientific research, making it a trusted partner in laboratories worldwide. Eppendorf's dedication to quality and innovation solidifies its position as a market leader in the life sciences sector.
DitchCarbon Score
How does Eppendorf's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eppendorf's score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eppendorf's reported carbon emissions
In 2022, Eppendorf SE reported total carbon emissions of approximately 7009000 kg CO2e for Scope 1, 1805000 kg CO2e for Scope 2 (market-based), and a significant 246561000 kg CO2e for Scope 3 emissions, primarily from the use of sold products. The combined Scope 1 and 2 emissions amounted to about 8814000 kg CO2e. Comparatively, in 2021, Eppendorf's emissions were approximately 7076000 kg CO2e for Scope 1, 2023000 kg CO2e for Scope 2 (market-based), and 60686000 kg CO2e for Scope 3, indicating a notable increase in Scope 3 emissions over the year. The total Scope 1 and 2 emissions for 2021 were about 9099000 kg CO2e. Eppendorf has committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is not currently committed to a net-zero target. Their climate initiatives are aligned with the pharmaceuticals, biotechnology, and life sciences sector, and they have made commitments to reduce emissions as part of their sustainability strategy. Eppendorf's emissions data is sourced directly from the company, with no cascading from a parent organization. The company continues to focus on sustainability and reducing its carbon footprint in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,644,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 13,202,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 81,784,000 | 00,000,000 | 00,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eppendorf is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
